ARS Pharmaceuticals, Inc. (SPRY) Earnings
|
Expand Research on SPRY
| Next EPS Date | 8/12/26 | EPS Growth Rate | +8.7% |
|---|---|---|---|
| Average EPS % Beat Rate | -10.1% | Revenue Growth Rate | +108.9% |
| Average % Move 1-Wk after EPS | -0.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/26  |
Q226 | N/A | -$0.42 | N/A | N/A | $32.84M | N/A | N/A | N/A | ||
| 5/15/26 | Q126 | -$0.61 | -$0.49 | -$0.12 | $22.7M | $22.67M | N/A |  | | Details | |
| 3/19/26 |
Q425 | N/A | -$0.42 | N/A | N/A | $26.9M | N/A | N/A | N/A | ||
| 11/10/25 | Q325 | -$0.52 | -$0.46 | -$0.06 | $32.5M | $28.56M | N/A | | | Details | |
| 8/13/25 | Q225 | -$0.46 | -$0.46 | $0.00 | $15.72M | $13.77M | N/A | | | Details | |
| 5/14/25 | Q125 | -$0.35 | -$0.34 | -$0.01 | $7.97M | $7.48M | N/A | | | Details | |
| 3/20/25 |
Q424 | N/A | -$0.13 | N/A | N/A | $5.1M | N/A | N/A | N/A | ||
| 11/13/24 |
Q324 | N/A | -$0.14 | N/A | N/A | $500K | N/A | N/A | N/A |
